Scheen A J
Département de Médecine, Université de Liège.
Rev Med Liege. 1998 Sep;53(9):518-23.
The most important drugs registered and/or launched in Belgium during the last year in the various disciplines of internal medicine will be briefly described. The originality of each molecule as well as its modalities of appropriate use in clinical practice will be stressed. This second part is devoted to drugs acting on infectious, rheumatoid, immunologic, oncologic and urogenital diseases.
将简要描述去年在比利时注册和/或上市的、用于各内科领域的最重要药物。将着重介绍每种药物分子的独特之处及其在临床实践中的合理使用方式。第二部分将介绍作用于感染性疾病、类风湿性疾病、免疫性疾病、肿瘤性疾病和泌尿生殖系统疾病的药物。
